BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

289 related articles for article (PubMed ID: 12882689)

  • 21. Beta 2-microglobulin and HLA-DR expression in relation to the presence of Epstein-Barr virus in nasopharyngeal carcinomas.
    Kouvidou C; Rontogianni D; Tzardi M; Datseris G; Panayiotides I; Darivianaki K; Karidi E; Delides G; Kanavaros P
    Pathobiology; 1995; 63(6):320-7. PubMed ID: 8738471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Guidelines for interpreting EBER in situ hybridization and LMP1 immunohistochemical tests for detecting Epstein-Barr virus in Hodgkin lymphoma.
    Gulley ML; Glaser SL; Craig FE; Borowitz M; Mann RB; Shema SJ; Ambinder RF
    Am J Clin Pathol; 2002 Feb; 117(2):259-67. PubMed ID: 11863222
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential expression of EBER1 in nontumor nasopharyngeal biopsies and nontumor component of nasopharyngeal carcinoma.
    Chen CL; Hsu MM; Hsu HC
    Intervirology; 1996; 39(4):230-5. PubMed ID: 9078463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deletion of Epstein-Barr virus latent membrane protein 1 gene in Japanese and Brazilian gastric carcinomas, metastatic lesions, and reactive lymphocytes.
    Hayashi K; Chen WG; Chen YY; Murakami I; Chen HL; Ohara N; Nose S; Hamaya K; Matsui S; Bacchi MM; Bacchi CE; Chang KL; Weiss LM
    Am J Pathol; 1998 Jan; 152(1):191-8. PubMed ID: 9422536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epstein-Barr virus detection in nasopharyngeal tissues of patients with suspected nasopharyngeal carcinoma.
    Tsai ST; Jin YT; Mann RB; Ambinder RF
    Cancer; 1998 Apr; 82(8):1449-53. PubMed ID: 9554519
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Correlation of Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) to fascin and phosphorylated Stat3 in nasopharyngeal carcinoma].
    Liu QY; Han AJ; You SY; Dong Y; Yang QX; Wu JH; Li MF
    Ai Zheng; 2008 Oct; 27(10):1070-6. PubMed ID: 18851787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular characterization of Epstein-Barr virus and oncoprotein expression in nasopharyngeal carcinoma in Korea.
    Jeon YK; Lee BY; Kim JE; Lee SS; Kim CW
    Head Neck; 2004 Jul; 26(7):573-83. PubMed ID: 15229899
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-encoded RNAs as a survival predictor in nasopharyngeal carcinoma.
    Ke K; Wang H; Fu S; Zhang Z; Duan L; Liu D; Ye J
    Chin Med J (Engl); 2014; 127(2):294-9. PubMed ID: 24438619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epstein-Barr virus-encoded small RNA 1 (EBER-1) could predict good prognosis in nasopharyngeal carcinoma.
    Zeng Z; Fan S; Zhang X; Li S; Zhou M; Xiong W; Tan M; Zhang W; Li G
    Clin Transl Oncol; 2016 Feb; 18(2):206-11. PubMed ID: 26260913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation of immunophenotype of sinonasal non-Hodgkin's lymphoma to Epstein-Barr virus infection.
    Feng YF; Wu QL; Zong YS
    Ai Zheng; 2007 Nov; 26(11):1170-6. PubMed ID: 17991313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epstein Barr virus associated pediatric nasopharyngeal carcinoma: its correlation with p53 and bcl-2 expression.
    Preciado MV; Chabay PA; De Matteo EN; Gismondi MI; Rey G; Zubizarreta P
    Med Pediatr Oncol; 2002 May; 38(5):345-8. PubMed ID: 11979459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pathogenic role of Epstein-Barr virus latent membrane protein-1 in the development of nasopharyngeal carcinoma.
    Yoshizaki T; Kondo S; Wakisaka N; Murono S; Endo K; Sugimoto H; Nakanishi S; Tsuji A; Ito M
    Cancer Lett; 2013 Aug; 337(1):1-7. PubMed ID: 23689138
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Association of Epstein-Barr virus with lymphoepithelioma-like carcinoma of the lung in southern China.
    Han AJ; Xiong M; Zong YS
    Am J Clin Pathol; 2000 Aug; 114(2):220-6. PubMed ID: 10941337
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression of Epstein-Barr virus genes in EBV-associated gastric carcinoma].
    Wang Y; Luo B; Zhao P; Huang BH
    Ai Zheng; 2004 Jul; 23(7):782-7. PubMed ID: 15248912
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stable expression of EBERs in immortalized nasopharyngeal epithelial cells confers resistance to apoptotic stress.
    Wong HL; Wang X; Chang RC; Jin DY; Feng H; Wang Q; Lo KW; Huang DP; Yuen PW; Takada K; Wong YC; Tsao SW
    Mol Carcinog; 2005 Oct; 44(2):92-101. PubMed ID: 16086371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between Epstein-Barr virus seroconversion and immunohistochemical changes in tonsils of pediatric solid organ transplant recipients.
    Shapiro NL; Tang CG; Bhattacharyya N
    Laryngoscope; 2011 Aug; 121(8):1718-25. PubMed ID: 21792960
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus infection in nasopharyngeal lymphoid hyperplasia.
    Zong Y; Zhang J; Li Z; Chen G; Rong Z; Wu W
    Chin Med J (Engl); 1999 Sep; 112(9):845-9. PubMed ID: 11717959
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus (EBV) latent membrane protein 1 induces interleukin-8 through the nuclear factor-kappa B signaling pathway in EBV-infected nasopharyngeal carcinoma cell line.
    Ren Q; Sato H; Murono S; Furukawa M; Yoshizaki T
    Laryngoscope; 2004 May; 114(5):855-9. PubMed ID: 15126743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of transcripts initiated from two viral promoters (Cp and Wp) in Epstein-Barr virus-infected nasopharyngeal carcinoma cells and biopsies.
    Chang Y; Sheen TS; Lu J; Huang YT; Chen JY; Yang CS; Tsai CH
    Lab Invest; 1998 Jun; 78(6):715-26. PubMed ID: 9645762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epstein-Barr Virus in Nasopharyngeal Carcinoma of Guatemalan and Brazilian Patients.
    Rumayor PiƱa A; Dos Santos HT; Carlos R; Altemani A; de Almeida OP
    Int J Surg Pathol; 2017 Jun; 25(4):304-309. PubMed ID: 27881609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.